Accustem Sciences Inc. (ACUT)
USD 0.55
(14.58%)
USD 0.55
(14.58%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 939.68 Thousand USD | -30.57% |
| 2021 | 1.35 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 247.55 Thousand USD | -73.66% |
| 2023 Q3 | 257.57 Thousand USD | -43.83% |
| 2023 Q2 | 458.53 Thousand USD | 85.22% |
| 2022 Q3 | 1.62 Million USD | -31.88% |
| 2022 Q2 | 2.38 Million USD | -26.76% |
| 2022 Q1 | 3.25 Million USD | 140.3% |
| 2022 FY | 939.68 Thousand USD | -30.57% |
| 2022 Q4 | 939.68 Thousand USD | -42.09% |
| 2021 Q4 | 1.35 Million USD | 0.0% |
| 2021 FY | 1.35 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -40579.177% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 52.012% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 91.096% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -70.197% |
| Rebus Holdings, Inc. | 5000.00 USD | -18693.78% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 99.278% |
| Qrons Inc. | 420.00 USD | -223635.476% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -21.936% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 96.637% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -95.542% |
| Skye Bioscience, Inc. | 11.94 Million USD | 92.13% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 97.581% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 86.984% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1130.7% |
| SQZ Biotechnologies Company | 107.18 Million USD | 99.123% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | 34.381% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1198.541% |
| Mesoblast Limited | 667.9 Million USD | 99.859% |
| Marizyme, Inc. | 22.01 Million USD | 95.732% |
| Genus plc | 1.02 Billion USD | 99.909% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | 30.821% |
| Pharming Group N.V. | 462.85 Million USD | 99.797% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 71.636% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -88.3% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -49.871% |
| ContraFect Corporation | 20.67 Million USD | 95.456% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -140.72% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -145.878% |
| IMV Inc. | 31.33 Million USD | 97.001% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 77.335% |
| MultiCell Technologies, Inc. | 126.22 USD | -744385.026% |
| ONE Bio Corp. | 70.08 Million USD | 98.659% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 99.269% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -117.665% |
| Q BioMed Inc. | 3.51 Million USD | 73.27% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 97.329% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -259.652% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1172.964% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.789% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 35.142% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 96.869% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 65.784% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -36.685% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 63.902% |
| GB Sciences, Inc. | 103.44 Thousand USD | -808.421% |
| Alpha Cognition Inc. | 2.45 Million USD | 61.679% |
| HST Global, Inc. | 1526.00 USD | -61478.571% |
| CSL Limited | 38.02 Billion USD | 99.998% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | 4.887% |
| Halberd Corporation | 10.13 Thousand USD | -9175.382% |
| Enzolytics Inc. | 361.7 Million USD | 99.74% |
| Agentix Corp. | 261.39 Thousand USD | -259.494% |
| Resverlogix Corp. | 8.11 Million USD | 88.42% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 49.96% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.979% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 98.03% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -46.905% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -4024.88% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 89.5% |
| AVAX Technologies, Inc. | 7.37 Million USD | 87.262% |
| Zenith Capital Corp. | 7410.00 USD | -12581.363% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.972% |
| Ember Therapeutics, Inc. | 184.00 USD | -510600.543% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -192.005% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -259.533% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -1.264% |
| Kadimastem Ltd | 2.3 Million USD | 59.216% |
| Helix BioMedix, Inc. | 3.02 Million USD | 68.937% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 98.217% |
| BioStem Technologies, Inc. | 14.56 Million USD | 93.546% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -1545.863% |
| LadRx Corporation | 2.3 Million USD | 59.283% |
| Cell Source, Inc. | 195.17 Thousand USD | -381.47% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -165.736% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -165.736% |
| NovAccess Global Inc. | 62.24 Thousand USD | -1409.589% |
| Affymax, Inc. | 7.44 Million USD | 87.375% |
| Itoco Inc. | 1.4 Million USD | 32.883% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -882.353% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -786.499% |
| Mobile Lads Corp. | 52.00 USD | -1806994.231% |
| CytoDyn Inc. | 11.13 Million USD | 91.562% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -557.254% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -5155.531% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -143.777% |
| SYBLEU INC | 330.46 Thousand USD | -184.351% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -129.516% |
| International Stem Cell Corporation | 5.39 Million USD | 82.566% |
| Bioxytran, Inc. | 137.63 Thousand USD | -582.725% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 93.736% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 94.332% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -1089.48% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -8.675% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 87.499% |
| Neutra Corp. | 2851.00 USD | -32859.979% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 97.1% |
| PureTech Health plc | 693.97 Million USD | 99.865% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 88.357% |
| IXICO plc | 15.84 Million USD | 94.069% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 88.654% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 99.091% |
| CSL Limited | 38.02 Billion USD | 99.998% |
| Cellectis S.A. | 333.99 Million USD | 99.719% |